247 related items for PubMed ID: 30173205
1. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J, Aldridge S, Thomas M, Cheetham T.
J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
[Abstract] [Full Text] [Related]
2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM, Stepien KM, Krishan A.
Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
[Abstract] [Full Text] [Related]
3. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Mar 19; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
4. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Mar 19; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
5. Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.
Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.
Horm Res Paediatr; 2018 Mar 19; 89(1):7-12. PubMed ID: 29073619
[Abstract] [Full Text] [Related]
6. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry.
Bacila I, Freeman N, Daniel E, Sandrk M, Bryce J, Ali SR, Yavas Abali Z, Atapattu N, Bachega TA, Balsamo A, Birkebæk N, Blankenstein O, Bonfig W, Cools M, Costa EC, Darendeliler F, Einaudi S, Elsedfy HH, Finken M, Gevers E, Claahsen-van der Grinten HL, Guran T, Güven A, Hannema SE, Higham CE, Iotova V, van der Kamp HJ, Korbonits M, Krone RE, Lichiardopol C, Luczay A, Mendonca BB, Milenkovic T, Miranda MC, Mohnike K, Neumann U, Ortolano R, Poyrazoglu S, Thankamony A, Tomlinson JW, Vieites A, de Vries L, Ahmed SF, Ross RJ, Krone NP.
Eur J Endocrinol; 2021 Apr 19; 184(4):553-563. PubMed ID: 33460392
[Abstract] [Full Text] [Related]
7. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.
Jääskeläinen J, Voutilainen R.
Pediatr Res; 1997 Jan 19; 41(1):30-3. PubMed ID: 8979286
[Abstract] [Full Text] [Related]
8. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I, Cutler GB.
Clin Endocrinol (Oxf); 1999 Sep 19; 51(3):285-91. PubMed ID: 10469007
[Abstract] [Full Text] [Related]
9. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
Endocr Pract; 2017 May 19; 23(5):546-556. PubMed ID: 28225306
[Abstract] [Full Text] [Related]
10. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 19; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
11. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP.
J Clin Endocrinol Metab; 2002 Jul 19; 87(7):3197-200. PubMed ID: 12107224
[Abstract] [Full Text] [Related]
12. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2017 Jan 19; 165(Pt B):396-406. PubMed ID: 27544322
[Abstract] [Full Text] [Related]
13. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Bonfig W, Schwarz HP.
Clin Endocrinol (Oxf); 2014 Dec 19; 81(6):871-5. PubMed ID: 24818525
[Abstract] [Full Text] [Related]
14. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
Roche EF, Charmandari E, Dattani MT, Hindmarsh PC.
Clin Endocrinol (Oxf); 2003 May 19; 58(5):589-96. PubMed ID: 12699440
[Abstract] [Full Text] [Related]
15. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.
Neumann U, van der Linde A, Krone RE, Krone NP, Güven A, Güran T, Elsedfy H, Poyrazoglu S, Darendeliler F, Bachega TASS, Balsamo A, Hannema SE, Birkebaek N, Vieites A, Thankamony A, Cools M, Milenkovic T, Bonfig W, Costa EC, Atapattu N, de Vries L, Guaragna-Filho G, Korbonits M, Mohnike K, Bryce J, Ahmed SF, Voet B, Blankenstein O, Claahsen-van der Grinten HL.
Eur J Endocrinol; 2022 Apr 11; 186(5):587-596. PubMed ID: 35290211
[Abstract] [Full Text] [Related]
16. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB.
J Pediatr Endocrinol Metab; 2012 Apr 11; 25(9-10):977-81. PubMed ID: 23426829
[Abstract] [Full Text] [Related]
17. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
J Clin Endocrinol Metab; 2001 Oct 11; 86(10):4679-85. PubMed ID: 11600525
[Abstract] [Full Text] [Related]
18. Gender dichotomy in long term growth trajectories of children with 21-hydroxylase deficiency congenital adrenal hyperplasia.
Patel L, Chandrashekhar SR, Gemmell I, O'Shea E, Jones J, Banerjee I, Amin R, Clayton P.
Horm Res Paediatr; 2011 Oct 11; 75(3):206-12. PubMed ID: 20962509
[Abstract] [Full Text] [Related]
19. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
J Clin Endocrinol Metab; 1995 Jul 11; 80(7):2238-43. PubMed ID: 7608286
[Abstract] [Full Text] [Related]
20. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
Horm Res; 1997 Jul 11; 47(1):17-22. PubMed ID: 9010713
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
